MDT

Medtronic
D

MDT

Arincen70/100B

Medtronic balance sheet 1986–2027

Medtronic had 8.82B USD in cash and short-term investments on 31 July 2026, against total debt of 28.15B USD: net debt of 19.33B USD.

Total assets Total liabilities Shareholders' equity

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
Latest
Q1 FY2027
FY2026
24 Apr 2026
FY2025
25 Apr 2025
FY2024
26 Apr 2024
FY2023
28 Apr 2023
FY2022
29 Apr 2022
FY2021
30 Apr 2021
FY2020
30 Apr 2020
FY2019
26 Apr 2019
FY2018
27 Apr 2018
FY2017
28 Apr 2017
Cash and equivalents
1.69B1.95B2.22B1.28B1.54B3.71B3.59B4.14B4.39B3.67B4.97B
Short-term investments
7.13B7.27B6.75B6.72B6.42B6.86B7.22B6.81B5.46B7.56B8.74B
8.82B9.22B8.97B8.01B7.96B10.57B10.82B10.95B9.85B11.23B13.71B
Cash growth
+8.60%+2.84%+11.99%+0.58%-24.72%-2.26%-1.20%+11.17%-12.28%-18.10%+8.50%
Receivables
224.00M6.64B6.52B6.13B6.00B5.55B5.46B4.65B6.22B5.99B5.59B
Inventory
-240.00M5.95B5.48B5.22B5.29B4.62B4.31B4.23B3.75B3.58B3.34B
Other current assets
15.59B2.97B2.86B2.59B2.43B2.32B1.96B2.21B2.14B2.19B2.24B
Total current assets
24.39B24.79B23.81B21.94B21.68B23.06B22.55B22.03B21.97B22.98B24.87B
Property, plant and equipment
-503.00M7.42B6.84B6.13B5.57B5.41B5.22B4.83B4.68B4.60B4.36B
Long-term investments
1.31B0.000.000.000.000.000.000.000.000.000.00
Goodwill and intangibles
53.43B52.73B53.40B54.21B56.27B56.10B59.70B58.90B60.52B61.27B61.92B
Goodwill
43.19B42.59B41.74B40.99B41.43B40.50B41.96B39.84B39.96B39.54B38.52B
Intangible assets
10.24B10.15B11.67B13.23B14.84B15.59B17.74B19.06B20.56B21.72B23.41B
Other non-current assets
14.69B8.09B7.62B7.70B7.44B6.41B5.61B4.93B2.53B2.54B8.70B
Total assets
93.31B93.03B91.68B89.98B90.95B90.98B93.08B90.69B89.69B91.39B99.82B
Accounts payable
2.70B2.64B2.45B2.41B2.66B2.28B2.11B2.00B1.95B1.63B1.56B
Deferred revenue
0.000.000.000.000.000.000.000.000.000.000.00
Short-term debt
2.54B1.78B2.87B1.09B13.00M3.74B2.00M2.77B832.00M2.06B7.52B
Other current liabilities
5.51B2.68B2.52B2.38B1.95B2.12B2.48B2.10B2.19B1.99B1.94B
Total current liabilities
11.80B11.66B12.88B10.79B9.05B12.39B8.51B10.37B8.47B10.08B14.26B
Long-term debt
25.62B26.12B25.59B23.88B24.29B20.32B26.32B21.98B24.47B23.68B25.86B
Other non-current liabilities
4.59B4.76B4.50B4.33B5.18B4.61B5.57B6.26B5.26B5.36B6.40B
Lease obligations, current
0.006.00M6.00M6.00M7.00M6.00M9.00M5.00M6.00M5.00M5.00M
Lease obligations, long-term
52.00M54.00M52.00M55.00M57.00M56.00M62.00M45.00M10.00M21.00M23.00M
Total liabilities
42.46B42.96B43.42B39.56B39.28B38.26B41.48B39.82B39.48B40.57B49.40B
Common stock and paid-in capital
-247.00M0.000.000.000.000.000.000.000.000.000.00
Retained earnings
33.19B32.64B31.48B30.40B30.39B30.25B28.59B28.13B26.27B24.38B23.36B
Accumulated other comprehensive income
-3.76B-4.10B-4.28B-3.32B-3.50B-2.27B-3.49B-3.56B-2.71B-1.79B-2.61B
Shareholders' equity
50.23B49.46B48.02B50.21B51.48B52.55B51.43B50.74B50.09B50.72B50.29B
Minority interest
618.00M609.00M232.00M206.00M182.00M171.00M174.00M135.00M121.00M102.00M122.00M
28.15B27.96B28.52B25.02B24.36B24.11B26.39B24.80B25.32B25.76B33.40B
Net cash
-19.33B-18.74B-19.55B-17.02B-16.41B-13.54B-15.57B-13.85B-15.47B-14.54B-19.69B
Working capital
12.59B13.13B10.94B11.15B12.62B10.67B14.04B11.67B13.50B12.90B10.61B
Book value per share
39.0938.4037.2337.7538.6338.8937.9837.5536.9037.0736.15
Tangible book value
-3.19B-3.27B-5.38B-4.00B-4.79B-3.55B-8.27B-8.17B-10.43B-10.55B-11.63B
Tangible book value per share
-2.48-2.54-4.17-3.00-3.59-2.62-6.11-6.04-7.68-7.71-8.36
Current ratio
2.072.131.852.032.391.862.652.132.592.281.74
Debt to equity
0.560.570.590.500.470.460.510.490.510.510.66

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

Common questions about Medtronic's cash and debt

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.